バイオメディカル組込みシステムの世界市場：2024～2031年

世界のバイオメディカル組込みシステムの市場規模は、2023年に1億7,025万米ドルに達し、2024～2031年にかけてCAGR 9.7%で成長し、2031年には3億4,874万米ドルに達すると予測されています。

バイオメディカル組込みシステムは、ハードウェアとソフトウェアコンポーネントを統合した電子システムであり、人間の健康のさまざまな側面を監視、診断、管理します。これらのシステムは、マイクロコントローラー、センサー、その他のコンポーネントで構成され、生理学的データを収集・処理するために協働します。ウェアラブル、埋め込み型、診断ツールなどの医療機器に組み込まれ、リアルタイムの情報提供、精度の向上、患者の転帰の改善を可能にします。

市場力学：

促進要因と抑制要因

慢性疾患の増加

近年、慢性疾患の増加に伴い、診断、予後、患者管理などの遠隔医療用途に対するニーズが高まっています。組込みシステム技術は、バイオメディカル技術において重要な領域を占めています。特に、パンデミックのような感染症が流行する過程で、医療従事者の安全性を高める目的のツールを開発するためです。

例えば、CDCによると、2024年、米国では、心臓病、がん、糖尿病、肥満、高血圧など、少なくとも1つの主要な慢性疾患を持つ人が1億2,900万人に上ります。米国の主要死因上位10のうち5つが、予防・治療可能な慢性疾患に関連しています。

過去20年間、有病率は着実に増加しており、この傾向は今後も続くと予想されます。複数の慢性疾患を抱えるアメリカ人の割合は増加しており、42％が2つ以上、12％が少なくとも5つの慢性疾患を抱えています。慢性疾患は米国のヘルスケアシステムにも大きな影響を与えており、年間4兆1,000億米ドルの支出の90％を占めています。

セキュリティ侵害やサイバー脅威に対する組込みシステムの脆弱性

産業の成長を鈍らせる主な要因のひとつに、組込み機器のセキュリティがあります。軍隊、銀行、データセンター、ヘルスケア施設はすべて、潜在的に重要な情報を保持するために、メモリを含む組込みデバイスに依存しています。そのため、サイバーセキュリティのリスクや侵害は何としても避けなければならないです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 慢性疾患の増加
    • 機器の進歩
  • 抑制要因
    • セキュリティ侵害やサイバー脅威に対する組込みシステムの脆弱性
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 特許分析
• PESTLE分析
• SWOT分析
• DMIオピニオン

第6章 コンポーネント別

• ソフトウェア
• ハードウェア

第7章 用途別

• ウェアラブル機器
• インプラント機器
• 診断機器
• 治療機器

第8章 エンドユーザー別

• 病院
• 診療所
• 在宅医療
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• 合併・買収分析

第11章 企業プロファイル

• Medtronic plc
• Philips Healthcare
• Siemens Healthineers
• General Electric（GE）Healthcare
• Roche Diagnostics
• Johnson & Johnson
• Abbott Laboratories
• Boston Scientific Corporation
• Texas Instruments
• Analog Devices

第12章 付録

Overview

Global Biomedical Embedded Systems Market reached US$ 170.25 million in 2023 and is expected to reach US$ 348.74 million by 2031, growing at a CAGR of 9.7% during the forecast period 2024-2031.

Biomedical embedded systems are electronic systems that integrate hardware and software components to monitor, diagnose, and manage various aspects of human health. These systems, consisting of microcontrollers, sensors, and other components, work together to collect and process physiological data. They are embedded in medical devices like wearables, implantables, and diagnostic tools, enabling real-time information delivery, enhanced accuracy, and improved patient outcomes.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic diseases

In recent years, with the rise of chronic diseases, there has been a growing need for telemedicine applications such as diagnosis, prognosis, and patient management. Embedded system technologies have occupied an important area in biomedical technology. Especially, to develop tools for the purposes of increasing the safety of healthcare workers in the event of epidemic infectious diseases in processes such as pandemics.

For instance, according to the CDC, in 2024, the US has 129 million people with at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Five of the top 10 leading causes of death in the US are associated with preventable and treatable chronic diseases.

Over the past two decades, prevalence has steadily increased, and this trend is expected to continue. An increasing proportion of Americans are dealing with multiple chronic conditions, with 42% having two or more and 12% having at least five. Chronic diseases also significantly impact the US healthcare system, accounting for 90% of annual $4.1 trillion expenditure.

Vulnerability of embedded systems to security breaches and cyber threats

One of the key factors slowing industry growth is the security of embedded devices. Military forces, banks, data centers, and healthcare facilities all rely on embedded devices, including memory, to retain potentially critical information. As a result, cybersecurity risks and breaches must be avoided at all costs.

Segment Analysis

The global biomedical embedded systems market is segmented based on component, application, end-user, and region.

The software from the component segment accounted for approximately 54.1% of the biomedical embedded systems market share

Software is a vital component in the biomedical embedded systems market, enhancing the functionality and efficiency of medical devices. It integrates complex algorithms and data processing capabilities, managing and interpreting medical data, controlling hardware components, and ensuring real-time responsiveness.

Software also aids in the development of advanced diagnostics, monitoring, and therapeutic solutions, while supporting regulatory compliance and security measures. As technology advances, software continues to drive innovation and improve the accuracy and reliability of biomedical embedded systems.

For instance, in November 2023, SolidWorld Group S.p.A. upgraded its Electrospider, the first three-dimensional bioprinter capable of replicating human cell tissue, with the incorporation of advanced proprietary Artificial Intelligence. This technological advancement represents a significant step in the future of biomedical engineering.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to advancements in healthcare technology and increasing demand for advanced medical devices. The region benefits from a strong healthcare infrastructure, high investment in research and development, and a robust presence of leading medical technology companies. Innovations like wearable health monitors, advanced diagnostic tools, and remote patient management systems are crucial for personalized healthcare and improving patient outcomes. North American regulations promote high-quality, safe, and reliable medical devices.

Market Segmentation

By Component

• Software
• Hardware

By Application

• Wearable Devices
• Implantable Devices
• Diagnostic Devices
• Therapeutic Devices

By End User

• Hospitals
• Clinics
• Home care settings
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Medtronic plc, Philips Healthcare, Siemens Healthineers, General Electric (GE) Healthcare, Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Texas Instruments, Analog Devices among others.

Key Developments

• In January 2022, Onera Health announced the introduction of its first Onera Biomedical-Lab-on-Chip. The biomedical sensor system-on-chip acquires and processes multiple biosignals and is designed for a broad range of wearable health applications and devices, offering many solutions and opportunities for innovation in the medical, wellness, and fitness space.

Why Purchase the Report?

• To visualize the global biomedical embedded systems market segmentation based on component, application, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the biomedical embedded systems market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global biomedical embedded systems market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Component
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rise in the prevalence of chronic diseases
    • 4.1.1.2. Advancements in the devices
  • 4.1.2. Restraints
    • 4.1.2.1. Vulnerability of embedded systems to security breaches and cyber threats
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Patent Analysis
• 5.6. PESTLE Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Component

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 6.1.2. Market Attractiveness Index, By Component
• 6.2. Software*
  • 6.2.1. Introduction
• 6.3. Hardware

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
• 7.2. Market Attractiveness Index, By Application
• 7.3. Wearable Devices*
  • 7.3.1. Introduction
  • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.4. Implantable Devices
• 7.5. Diagnostic Devices
• 7.6. Therapeutic Devices

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Clinics
• 8.4. Home care settings
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Medtronic plc*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Philips Healthcare
• 11.3. Siemens Healthineers
• 11.4. General Electric (GE) Healthcare
• 11.5. Roche Diagnostics
• 11.6. Johnson & Johnson
• 11.7. Abbott Laboratories
• 11.8. Boston Scientific Corporation
• 11.9. Texas Instruments
• 11.10. Analog Devices

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us